Heart stem cell trial pulled before it even started
Disease control
Terminated
This trial aimed to test whether umbilical cord stem cells, delivered through a catheter into heart arteries, could safely improve heart function in people with severe heart damage after a major heart attack. It was designed for patients with very weak hearts (ejection fraction b…
Phase: PHASE1 • Sponsor: Shanghai Life Science & Technology • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC